TITLE:
Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis

CONDITION:
Cystic Fibrosis

INTERVENTION:
interferon gamma-1b

SUMMARY:

      The purpose of this research study is to evaluate the safety, tolerability, and efficacy of
      Interferon gamma-1b (IFN-gamma 1b) when administered by subcutaneous injection over a period
      of 4 weeks to patients with mild-to-moderate cystic fibrosis. Additionally, preliminary
      assessments on the effects of IFN-gamma 1b on lung function and other indicators of health
      will be made.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 6 Years to N/A
Criteria:

        -  At least 6 years of age

          -  Diagnosis of cystic fibrosis (against certain criteria)

          -  Able to perform pulmonary (lung) function tests and participate in induced sputum
             procedures

          -  Pulmonary function values must meet certain minimal requirements

          -  Must have acceptable laboratory test results

          -  Cannot be on certain medications during and immediately prior to study

          -  Cannot have a history of unstable or deteriorating cardiac or neurologic disease
      
